Developing and commercialising advanced wound care therapies|Christian Behrenbruch,CEO,Factor Therapeutics Ltd 00:10:00
Dr Behrenbruch has over two decades of radiopharmaceuticals experience and a strong track record in global healthcare and biotechnology entrepreneurship and technology commercialisation. He brings a unique blend of technical expertise an executive leadership to guide Telix as it enters the next stage of its strategy.